• Citer

A dose escalation study of gemcitabine plus pemetrexed administered biweekly in patients with solid tumors.

par Kalykaki, A.;Vamvakas, Lambros;Agelaki, Sofia;Kalbakis, K;Vardakis, N;Sfakiotaki, G;Ignatiadis, Michail ;Saridaki, Z.;Karampeazis, A;Karabeazis, A;Mavroudis, Dimitris;Georgoulias, Vassilis
Référence Oncology, 71, 3-4, page (197-203)
Publication Publié, 2006

Article révisé par les pairs

• Détails
• Contenu

Titre:	A dose escalation study of gemcitabine plus pemetrexed administered biweekly in patients with solid tumors.
Auteur:	Kalykaki, A.; Vamvakas, Lambros; Agelaki, Sofia; Kalbakis, K; Vardakis, N; Sfakiotaki, G; Ignatiadis, Michail; Saridaki, Z.; Karampeazis, A; Karabeazis, A; Mavroudis, Dimitris; Georgoulias, Vassilis
Informations sur la publication:	Oncology, 71, 3-4, page (197-203)
Statut de publication:	Publié, 2006
Sujet CREF:	Cancérologie
	Médecine pathologie humaine
	Sciences bio-médicales et agricoles
MeSH keywords:	Adult
	Aged
	Aged, 80 and over
	Antineoplastic Combined Chemotherapy Protocols -- administration & dosage -- therapeutic use
	Deoxycytidine -- administration & dosage -- adverse effects -- analogs & derivatives
	Female
	Glutamates -- administration & dosage -- adverse effects
	Guanine -- administration & dosage -- adverse effects -- analogs & derivatives
	Humans
	Male
	Maximum Tolerated Dose
	Middle Aged
	Neoplasms -- drug therapy
	Pemetrexed
Langue:	Anglais
Identificateurs:	urn:issn:0030-2414
	info:doi/10.1159/000106069
	info:pii/000106069
	info:pmid/17641541